HOME >> BIOLOGY >> NEWS
NIAID awards grant to rapidly sequence the malaria mosquito genome

The National Institute of Allergy and Infectious Diseases (NIAID) today announced a $9 million award to help reveal the genetic secrets of malaria, a complex disease responsible for up to 3 million deaths worldwide each year. Through the grant to Celera Genomics Group, NIAID has expanded its efforts to determine the genetic blueprint of Anopheles gambiae, a mosquito species that transmits the malaria parasite to people. As part of an international consortium of A. gambiae researchers and genome sequencing centers, Celera scientists will help sequence the mosquito genome and make the information freely available to the scientific community. Celera anticipates completing the project next spring.

Malaria is caused by parasites of the genus Plasmodium. The disease strikes 300 to 500 million people annually, 90 percent of who live in sub-Saharan Africa. More than 40 percent of the world's population lives in areas where malaria naturally occurs.

Malaria parasites undergo a complex life cycle; to thrive and spread they must spend parts of their lives in both humans and mosquitoes. To learn more about how the parasite, mosquitoes and humans interact, researchers will study the Anopheles genome along with the recently deciphered human genome and the soon-to-be-completed DNA sequence of the deadliest malaria parasite, Plasmodium falciparum. The three genome sequences will provide scientists with a unique opportunity to study the natural history of malaria. For the first time, researchers will have the complete genetic information on an infectious organism, its natural host, and the insect that transmits the disease from person to person.

"This initiative will give us the pieces to an incredibly complex puzzle," says NIAID Director Anthony S. Fauci, M.D. "By analyzing and comparing the genomes of all three organisms, researchers will have a wealth of new information for understanding malaria and how it is spread, and for use in developing
'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
8-Aug-2001


Page: 1 2

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID unveils bioterrorism research agenda
3. NIAID takes next genome step
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Chemical engineering grad students will take notable national awards
9. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
10. NSF awards 22 new projects for plant genome research
11. The American Phytopathological Society announces 2004 awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017  IBM ... in dairy research, today announced a new collaboration using ... the chances that the global milk supply is impacted ... project, Cornell University has become the newest academic institution ... Chain, a food safety initiative that includes IBM Research, ...
(Date:5/23/2017)...  Hunova, the first robotic gym for the rehabilitation and functional motor ... Genoa, Italy . The first 30 robots will be ... USA . The technology was developed and patented at the ... spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur ... ...
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
Breaking Biology Technology:
Cached News: